123 related articles for article (PubMed ID: 22972709)
1. Hierarchical non-negative matrix factorization (hNMF): a tissue pattern differentiation method for glioblastoma multiforme diagnosis using MRSI.
Li Y; Sima DM; Cauter SV; Croitor Sava AR; Himmelreich U; Pi Y; Van Huffel S
NMR Biomed; 2013 Mar; 26(3):307-19. PubMed ID: 22972709
[TBL] [Abstract][Full Text] [Related]
2. Combination of feature-reduced MR spectroscopic and MR imaging data for improved brain tumor classification.
Simonetti AW; Melssen WJ; Szabo de Edelenyi F; van Asten JJ; Heerschap A; Buydens LM
NMR Biomed; 2005 Feb; 18(1):34-43. PubMed ID: 15657908
[TBL] [Abstract][Full Text] [Related]
3. Fast nosologic imaging of the brain.
De Vos M; Laudadio T; Simonetti AW; Heerschap A; Van Huffel S
J Magn Reson; 2007 Feb; 184(2):292-301. PubMed ID: 17118683
[TBL] [Abstract][Full Text] [Related]
4. Comparison of unsupervised classification methods for brain tumor segmentation using multi-parametric MRI.
Sauwen N; Acou M; Van Cauter S; Sima DM; Veraart J; Maes F; Himmelreich U; Achten E; Van Huffel S
Neuroimage Clin; 2016; 12():753-764. PubMed ID: 27812502
[TBL] [Abstract][Full Text] [Related]
5. Spectrum separation resolves partial-volume effect of MRSI as demonstrated on brain tumor scans.
Su Y; Thakur SB; Karimi S; Du S; Sajda P; Huang W; Parra LC
NMR Biomed; 2008 Nov; 21(10):1030-42. PubMed ID: 18759383
[TBL] [Abstract][Full Text] [Related]
6. An advanced MRI and MRSI data fusion scheme for enhancing unsupervised brain tumor differentiation.
Li Y; Liu X; Wei F; Sima DM; Van Cauter S; Himmelreich U; Pi Y; Hu G; Yao Y; Van Huffel S
Comput Biol Med; 2017 Feb; 81():121-129. PubMed ID: 28061367
[TBL] [Abstract][Full Text] [Related]
7. Robust discrimination of glioblastomas from metastatic brain tumors on the basis of single-voxel (1)H MRS.
Vellido A; Romero E; Julià-Sapé M; Majós C; Moreno-Torres Á; Pujol J; Arús C
NMR Biomed; 2012 Jun; 25(6):819-28. PubMed ID: 22081447
[TBL] [Abstract][Full Text] [Related]
8. Hierarchical non-negative matrix factorization to characterize brain tumor heterogeneity using multi-parametric MRI.
Sauwen N; Sima DM; Van Cauter S; Veraart J; Leemans A; Maes F; Himmelreich U; Van Huffel S
NMR Biomed; 2015 Dec; 28(12):1599-624. PubMed ID: 26458729
[TBL] [Abstract][Full Text] [Related]
9. Improving the classification of brain tumors in mice with perturbation enhanced (PE)-MRSI.
Simões RV; Ortega-Martorell S; Delgado-Goñi T; Le Fur Y; Pumarola M; Candiota AP; Martín J; Stoyanova R; Cozzone PJ; Julià-Sapé M; Arús C
Integr Biol (Camb); 2012 Feb; 4(2):183-91. PubMed ID: 22193155
[TBL] [Abstract][Full Text] [Related]
10. Automated vs. manual pattern recognition of 3D (1)H MRSI data of patients with prostate cancer.
Zechmann CM; Menze BH; Kelm BM; Zamecnik P; Ikinger U; Giesel FL; Thieke C; Delorme S; Hamprecht FA; Bachert P
Acad Radiol; 2012 Jun; 19(6):675-84. PubMed ID: 22578226
[TBL] [Abstract][Full Text] [Related]
11. The effect of combining two echo times in automatic brain tumor classification by MRS.
García-Gómez JM; Tortajada S; Vidal C; Julià-Sapé M; Luts J; Moreno-Torres A; Van Huffel S; Arús C; Robles M
NMR Biomed; 2008 Nov; 21(10):1112-25. PubMed ID: 18759382
[TBL] [Abstract][Full Text] [Related]
12. Measurements of diagnostic examination performance using quantitative apparent diffusion coefficient and proton MR spectroscopic imaging in the preoperative evaluation of tumor grade in cerebral gliomas.
Server A; Kulle B; Gadmar ØB; Josefsen R; Kumar T; Nakstad PH
Eur J Radiol; 2011 Nov; 80(2):462-70. PubMed ID: 20708868
[TBL] [Abstract][Full Text] [Related]
13. Convex non-negative matrix factorization for brain tumor delimitation from MRSI data.
Ortega-Martorell S; Lisboa PJ; Vellido A; Simões RV; Pumarola M; Julià-Sapé M; Arús C
PLoS One; 2012; 7(10):e47824. PubMed ID: 23110107
[TBL] [Abstract][Full Text] [Related]
14. Lipid and macromolecules quantitation in differentiating glioblastoma from solitary metastasis: a short-echo time single-voxel magnetic resonance spectroscopy study at 3 T.
Crisi G; Orsingher L; Filice S
J Comput Assist Tomogr; 2013; 37(2):265-71. PubMed ID: 23493217
[TBL] [Abstract][Full Text] [Related]
15. Proton magnetic resonance spectroscopy in the distinction of high-grade cerebral gliomas from single metastatic brain tumors.
Server A; Josefsen R; Kulle B; Maehlen J; Schellhorn T; Gadmar Ø; Kumar T; Haakonsen M; Langberg CW; Nakstad PH
Acta Radiol; 2010 Apr; 51(3):316-25. PubMed ID: 20092374
[TBL] [Abstract][Full Text] [Related]
16. Identification of MRI and 1H MRSI parameters that may predict survival for patients with malignant gliomas.
Li X; Jin H; Lu Y; Oh J; Chang S; Nelson SJ
NMR Biomed; 2004 Feb; 17(1):10-20. PubMed ID: 15011246
[TBL] [Abstract][Full Text] [Related]
17. Automated tissue segmentation and blind recovery of (1)H MRS imaging spectral patterns of normal and diseased human brain.
Du S; Mao X; Sajda P; Shungu DC
NMR Biomed; 2008 Jan; 21(1):33-41. PubMed ID: 17347991
[TBL] [Abstract][Full Text] [Related]
18. Dimethyl sulfoxide (DMSO) as a potential contrast agent for brain tumors.
Delgado-Goñi T; Martín-Sitjar J; Simões RV; Acosta M; Lope-Piedrafita S; Arús C
NMR Biomed; 2013 Feb; 26(2):173-84. PubMed ID: 22814967
[TBL] [Abstract][Full Text] [Related]
19. Unsupervised nosologic imaging for glioma diagnosis.
Li Y; Sima DM; Van Cauter S; Himmelreich U; Croitor Sava AR; Pi Y; Liu Y; Van Huffel S
IEEE Trans Biomed Eng; 2013 Jun; 60(6):1760-3. PubMed ID: 23192480
[TBL] [Abstract][Full Text] [Related]
20. Non-negative blind source separation techniques for tumor tissue typing using HR-MAS signals.
Croitor Sava A; Sima DM; Martinez-Bisbal MC; Celda B; Van Huffel S
Annu Int Conf IEEE Eng Med Biol Soc; 2010; 2010():3658-61. PubMed ID: 21096855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
